TP53 and hepatocellular carcinoma: In accordance with previous studies that reported 58% TP53 mutation rate in HCC patients 27 and TP53 mutation were significant prognostic factors associated with shorter survival 28, our data showed that 37.9% of HCC cases had TP53 mutations, which ranked TP53 as the most mutated gene in our cohort.